The endocochlear potential (EP) is essential to hearing, because it provides approximately half of the driving force for the mechanoelectrical transduction current in auditory hair cells. The EP is produced by the stria vascularis (SV), a vascularized bilayer epithelium of the cochlea lateral wall. The absence of the gap junction protein connexin30 (Cx30) in Cx30 ؊/؊ mice results in the SV failure to produce an EP, which mainly accounts for the severe congenital hearing impairment of these mice. Here, we show that the SV components of the EP electrogenic machinery and the epithelial barriers limiting the intrastrial fluid space, which are both necessary for the EP production, were preserved in Cx30 ؊/؊ mice. In contrast, the endothelial barrier of the capillaries supplying the SV was disrupted before EP onset. This disruption is expected to result in an intrastrial electric shunt that is sufficient to account for the absence of the EP production. 
I
ntercellular communication through gap junctions (GJs) is essential for various developmental processes and organ functions, including audition. Defects in the genes encoding Cx26 (GJB2), Connexin30 (Cx30) (GJB6), Cx31 (GJB3), and Cx43 (GJA1), four Cx proteins that form GJs, cause hearing impairment (http://davinci.crg.es/deafness/index.php) (1) . In the mammalian auditory organ, the cochlea, most cells are coupled to their neighbors by GJs, thereby forming at least two independent cellular networks (2) . The epithelial network connects nonsensory supporting cells of the sensory epithelium (organ of Corti) and adjacent epithelial cells. Unpaired Cxs (hemichannels) have also been described in the supporting cells (3) . The connective tissue network connects the fibrocytes of the spiral ligament, as well as the basal and intermediate cells of the stria vascularis (SV) but not the SV marginal cells (Fig. 1) .
Cochlear GJ channels consist mainly of Cx26 and Cx30 (2) . Studies of mutant mice deficient in Cx26 and Cx30 have shown that these Cxs are essential for the survival of the organ of Corti (4) (5) (6) . It has been suggested that GJs are essential for buffering extracellular K ϩ ions at the base of the sensory hair cells (4, 6) . In addition, in vitro experiments have provided strong evidence that Cx26-linked deafness is associated with a defect in the diffusion of the second messenger inositol 1,3,4-triphosphate through the cochlear epithelial GJ network (7) .
The absence of functional Cx30 causes severe deafness in man and mouse (8, 9) . This deafness results from both impaired production of the endocochlear potential (EP) and degeneration of the organ of Corti (6) . The EP is a transepithelial electric potential difference of approximately ϩ80 mV, established between the endolymphatic and perilymphatic compartments of the mammalian cochlea. It starts to develop on postnatal day (P)6 in the mouse (10) and reaches adult values around P12-P14. The EP plays a key role in sound transduction, because it constitutes approximately half of the force that drives cations from the endolymph, a K ϩ -rich extracellular fluid, into the sensory hair cells through mechanoelectrical transduction channels (11) . The EP is produced by the SV, a vascularized epithelium of the cochlea lateral wall (12) . The SV is limited on one side by the marginal cells and, on the other side, by the basal and intermediate cells. Tight junctions (TJ) between marginal cells and between basal cells insulate an extracellular fluid space, termed the intrastrial space, from the endolymphatic and perilymphatic spaces, respectively (Fig. 1) . The intrastrial space houses a dense capillary network, that supports the SV high metabolic rate (13) (14) (15) (16) (17) (18) (Fig. 1) . These nonfenestrated capillaries are formed by endothelial cells linked by TJs that insulate the intrastrial fluid from blood (15) .
The EP is a K ϩ diffusion electric potential generated across the apical membrane of the SV intermediate cells. It is produced by KCNJ10 potassium inwardly rectifying channel, subfamily J, member 10 K ϩ channels in concert with the normally high cytosolic K ϩ concentration of intermediate cells and the very low K ϩ concentration in the intrastrial fluid space (12) . The electric potential produced in the intrastrial space is almost maintained through the marginal cell layer (Fig. 1) . Uptake of K ϩ ions from the intrastrial f luid occurs via Na ϩ /K ϩ -ATPase, H ϩ /K ϩ -ATPase, and Na ϩ /K ϩ /2Cl Ϫ cotransporter in the basal membrane
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of the marginal cells (12, 19) . These cells secrete K ϩ ions in the endolymph through KCNQ1/KCNE1 K ϩ channels located in their apical membrane (20) (Fig. 1) .
Here, we investigated the mechanism by which the absence of Cx30 in Cx30 Ϫ/Ϫ mice results in the SV failure to produce an EP.
Results

The SV Electrogenic Machinery and the Marginal and Basal Cell
Barriers Are Normal in Cx30 ؊/؊ Mice. So far, all defects of EP production associated with deafness have been reported to be caused by abnormalities in the SV electrogenic components (12, 19) or basal cell barrier (21, 22) . With the exception of Kcnj10 inactivation in the mouse, which results in only a 50% reduction of the endolymphatic K ϩ concentration (23) , all reported alterations of the SV electrogenic components have been shown to abolish the secretion of K ϩ , which leads to the collapse of the endolymphatic compartment (20, 24, 25) . In contrast, disruption of the basal cell barrier of the SV does not affect the K ϩ secretory function of the SV (22) . We first tested whether EP failure in Cx30 Ϫ/Ϫ mice could result from a defect in the SV electrogenic machinery. In P13 Cx30 Ϫ/Ϫ mice (i.e., before the organ of Corti degenerates in these mice), the K ϩ concentration and volume of the endolymph are normal (6), suggesting that the K ϩ secretory function of the SV is not affected. Accordingly, we found that the immunolabelings of Kcnq1, Kcne1, Kcnj10, and H ϩ /K ϩ -ATPase in cochlear sections from Cx30 Ϫ/Ϫ mice were similar to those from wild-type mice [see supporting information (SI) Fig. 7 ]. Together, these observations suggest that the electrogenic machinery of the SV is preserved in Cx30 Ϫ/Ϫ mice. We next investigated basal and marginal TJ barriers in the SV. The distribution of occludin, an integral membrane protein of TJs, in the basal and marginal cell layers, was indistinguishable between Cx30 Ϫ/Ϫ and wild-type mice ( Fig. 2A) . Similar results were obtained for the zona occludens protein-1 (ZO-1), a PDZ domain-containing submembranous scaffold protein associated with TJs (see SI Fig. 8 ). Of note, Cx30 is the only Cx that does not interact with ZO-1 (26) . We then tested the functionality of the paracellular barrier formed by these TJs, by perfusing HRP into the perilymphatic and endolymphatic spaces of wild-type and Cx30 Ϫ/Ϫ cochleas. In both mutant and wild-type mice, peroxidase activity was detected in all cochlear tissues, except the SV epithelium (Fig. 2B) , showing that HRP did not cross the SV basal or marginal cell layers. Incidentally, this result also indicates the effectiveness of the seals at the sites where spiral ligament vessels penetrate into the SV through its basal cell layer (13, 14) . The only labeling seen in the SV resulted from the endogenous peroxidase activity of blood cells within the capillaries (Fig. 2) . Finally, topographic analysis of TJs in the basal and marginal cell layers of the SV by freeze-fracture electron microscopy failed to detect any difference between wild-type and Cx30 in the spiral ligament adjacent to the SV (Fig. 1) . From P3 to P9, this pool splits into two vascular networks, the spiral ligament and the SV networks (13, 16) . Endothelial cells of the SV capillaries are linked by TJs and form a barrier between blood and the intrastrial space, which reaches maturity by P14 (15) . Electron microscopy of cochlea lateral wall tissue samples collected at P13 and P28 showed marked abnormalities of the SV capillaries in Cx30 Ϫ/Ϫ mice ( Fig. 3) . Thus, many of these capillaries were delimited by multiple layers of endothelial cells, rather than the normal single layer ( Fig. 3 A-D) . The basal lamina was often split into several sheets ( Fig. 3 C and F), and intercellular spaces were enlarged at membrane interfaces, with junctional regions appearing as electron-transparent zones ( Fig. 3 C-F ). In contrast, no such abnormalities were detected in the spiral ligament capillaries of these mice (data not shown). These observations led us to assess functional integrity of the SV endothelial barrier. Cochlear sections from P5 to P14 and from P30 mice were immunolabeled for Ig heavy and light chains and albumin (27) . From P10 onward, these serum proteins were detected outside the SV capillaries in Cx30 Ϫ/Ϫ mice but not in control littermates (Fig. 4) . Such a labeling was observed neither in the spiral ligament of Cx30 Ϫ/Ϫ mice ( Fig. 4 B and D) nor in their skin and brain, two tissues where Cx30 is also expressed (data not shown). Thus, the absence of Cx30 results in the selective disruption of the endothelial barrier in the SV capillaries.
The Epithelial Cells of the SV Are Not Dye-Coupled to Nearby Endothelial Cells. To determine the mechanism underlying the capillary abnormalities, we first immunolabeled Cx30 in microdissected SV from P10 and P15 wild-type mice. At both time points, a punctate staining was detected around the capillaries (Fig. 5A) , which did not overlap with the isolectin labeling of endothelial cells, indicating that endothelial cells do not express Cx30 (Fig. 5A) . We next investigated intercellular coupling between the various cell types in freshly microdissected SVs of P15 wild-type mice, by intracellular injections of either neurobiotin (NBN; charge, 1; molecular mass, 287 Da), which permeates Cx30-containing GJs (28), or lucifer yellow (LY; charge, 2; molecular mass, 443 Da), a dye that poorly permeates Cx30-containing GJs (28) . NBN Table 1 ). The presence of Cx26 in Cx30 Ϫ/Ϫ basal and intermediate cells (6) may account for the persistence of a GJ coupling in these cells even in the absence of Cx30. To further investigate the pathogenesis of the SV vascular anomalies, we compared on microarrays the transcriptome of microdissected SV from P13 Cx30 Ϫ/Ϫ and wildtype mice (ArrayExpress accession no. E-MEXP-558). In agreement with our immunostaining experiments (see above), we did not detect abnormal transcription of genes encoding proteins of the SV electrogenic machinery in Cx30 Ϫ/Ϫ mice. The transcription levels of other Cx genes were also not affected. In contrast, several genes associated with vascular physiology showed abnormal transcription levels (see SI Table 2 for the list of vascular-related transcriptional modifications with a log 2 ratio above or below 1), including genes that encode angiogenic transcription factors, molecules involved in vascular remodeling and vascular tone regulation, and extracellular matrix proteins. In addition, the expression of several early transcription factor genes (Jun, Fos, Egr1, and Egr2) was strongly up-regulated. These transcriptional events, as well as others listed in SI Table 3 have also been observed in neurodegenerative diseases. The largest change in Cx30 Ϫ/Ϫ mice was a decrease of the transcription level of Bhmt, which encodes betaine Hcy Smethyltransferase, to 1/8th of the wild-type value. Bhmt catalyzes the transfer of a methyl group from betaine to Hcy, a nonprotein sulfur amino acid (29) . Quantitative RT-PCR analysis confirmed the down-regulation of Bhmt in the SV of Cx30 Ϫ/Ϫ mice (Fig. 6A ). In contrast, the Bhmt transcription level was not modified in the organ of Corti, spiral ligament, and brain of Cx30 Ϫ/Ϫ mice (Fig. 6A ). Altered transcription of two other genes that may also contribute to the increase in Hcy was also found in the SV of Cx30 Ϫ/Ϫ mice. Thus, Sahh, which encodes S-adenosyl Hcy hydrolase, an enzyme involved in Hcy synthesis from methionine (30) , was up-regulated 1.4-fold over control values, whereas Gsto1, which encodes the GST omega 1, a thiol-transferase that may metabolize Hcy (31), was down-regulated 2.2-fold under control levels. The expression of other genes encoding enzymes for the remethylation and transsulfuration pathways of Hcy (29) was unaffected. In the kidney, inhibition of Bhmt results in the accumulation of Hcy (32) . Because the SV compartment is too small to directly assay the activity of Bhmt (33) as well as to determine the concentration of Hcy by HPLC (34), we analyzed Hcy levels by immunolabeling cochlear sections (35) , using a Hcy-specific polyclonal antibody. From P10 onward, i.e., when the SV endothelial barrier is disrupted, a strong Hcy immunostaining was observed in all SV cell types in Cx30 Ϫ/Ϫ mice (Fig. 6C) , whereas the SV was not immunoreactive in wildtype mice (Fig. 6B) . Hcy immunoreactivity was not modified elsewhere in the cochlea or brain of Cx30 Ϫ/Ϫ mice. Consistent with these findings, we did not find any change in the Hcy plasma concentration, or in the plasma thiol-redox status (see SI Fig. 10 ).
Discussion
EP defects underlying hearing impairment have been attributed to abnormalities in either the SV basal cell barrier (21, 22) or electrogenic components (12) . In Cx30 Ϫ/Ϫ mice, we found no indication for a defect in the marginal and basal TJ barriers or in the SV electrogenic machinery. Instead, we observed the loss of functional integrity of the SV endothelial barrier, as revealed by the presence of serum proteins outside of the SV capillaries. This alteration was associated with ultrastructural anomalies of the SV endothelial cells and SV capillary basal lamina. The electrical shunt between the intrastrial fluid and blood that is expected to occur as a consequence of the SV endothelial barrier disruption is sufficient to account for the absence of EP production in Cx30 Ϫ/Ϫ mice. Remarkably, the integrity of the spiral ligament vessels that are close to the SV was preserved, indicating the SV specificity of the vascular defect.
Both (17, 18) . The discrepancy may reflect differences in the microinjection technique and/or the animal species (gerbil or mouse) used in the different studies. Still, our findings are consistent with the lack of compelling ultrastructural evidence of GJs between the SV epithelial cells and endothelial cells or pericytes (2, 18) . Therefore, a possible explanation of the early abnormal SV vascular phenotype in Cx30 Ϫ/Ϫ mice is that the intermediate/basal cells normally control the maturation of the SV endothelial barrier by extracellular mediators, and that these unknown signals are absent (or present at insufficient levels) in Cx30 Ϫ/Ϫ mice. Release of these mediators into the intrastrial fluid space may require the presence of either Cx30-based GJs between basal and intermediate cells or nonjunctional hemichannels made by this Cx (36, 37) . Alternatively, deleterious mediators(s) might be produced in Cx30 Ϫ/Ϫ mice, as a result of the absence of Cx30. Hcy, for which immunoreactivity in the SV of Cx30 Ϫ/Ϫ mice was abnormally strong, is an attractive candidate. Indeed, it has been reported that high levels of Hcy cause endothelial dysfunction in vitro and in vivo (38, 39) .
Analysis of the SV transcriptome indicated a substantial decrease in the expression of Bhmt, encoding betaine-Hcy S-methyltransferase, which could be the main cause of Hcy elevation in Cx30 Ϫ/Ϫ mice. Significantly, the down-regulation of Bhmt was strictly limited to the SV and resulted in a local increase in the Hcy concentration. So far, all other Hcy-linked vascular disorders have been associated with an increased Hcy concentration in plasma (40, 41) and related to the altered functioning of enzymes, including methylenetetrahydrofolate reductase and cystathionine ␤-synthase (but not Bhmt), or to deficiencies in their cosubstrate (folate) and cofactor (vitamin B6) (29) . What then, could cause the down-regulation of Bhmt in the SV of Cx30 Ϫ/Ϫ mice? The mechanism is still unclear but it is noteworthy that Bhmt can be down-regulated in the kidney by high extracellular osmolarity (33) , and Cx30 hemichannels have been proposed to regulate salt reabsorption in this organ (42) . Therefore, we propose the following pathogenic scenario in the Cx30 Ϫ/Ϫ mice. The absence of Cx30 would provoke an osmotic imbalance in the SV. This would induce Bhmt downregulation that would result in elevated Hcy concentrations, leading to disruption of the SV endothelial barrier and consequently failure of EP production.
Materials and Methods
SV Dissection Procedure. Animals were killed by decapitation and the temporal bones retrieved; the inner ear was rapidly dissected and placed in cold PBS. After removal of the cochlear bone, the spiral ligament and SV were separated from the rest of the cochlea. With careful dissection, the SV strip was detached from the underlying connective tissue (spiral ligament).
Immunolabeling Experiments. We used FITC-conjugated streptavidin (Jackson ImmunoResearch Laboratory, West Grove, PA; 1:100) and the following antibodies: rabbit anti H ϩ /K ϩ -ATPase ␣ subunit polyclonal (Calbiochem, San Diego, CA; 1:500), anti-mouse ZO-1 monoclonal (Sigma, St. Louis, MO; 1:200), anti-mouse occludin monoclonal (Sigma; 1:200), rabbit anti-Hcy polyclonal (Chemicon International, Temecula, CA; 1:1,000), rat anti-mouse PECAM-1 monoclonal (BD PharMingen, San Diego, CA; 1:200), FITC-conjugated mouse antialbumin (Bethyl Laboratories, Montgomery, TX; 1:500), FITC-conjugated antiisolectin B4 (Sigma; 10 g/ml), anti-Kcnj10 (Alomone Laboratories, Jerusalam, Israel; 1:250), anti-Kcne1 (Alomone Laboratories; 1:250), anti-Kcnq1 (Alomone Laboratories; 1:250), rabbit anti-mouse Cx30 polyclonal (Zymed, Invitrogen, CergyPontoise, France; 1:500), Cy3-conjugated goat anti-mouse Ig(HϩL) (1:500), and biotin-conjugated anti-mouse Ig, kappa light chain (PharMingen; 1:100).
Experiments were performed using 10-m-thick frozen cochlear sections or strips of freshly dissected SV. We prepared cochlear sections by dissecting the temporal bones and fixing them by immersion in 4% paraformaldehyde at 4°C for 1 h. The bones were then decalcified in 0.5 M EDTA in PBS at 4°C for 24 h, immersed in 20% sucrose in PBS at 4°C for 12 h, and frozen in OCT compound embedding medium. For whole mounts, tissues were microdissected in PBS, fixed by immersion in 4% paraformaldehyde for 1 h, and rinsed three times in PBS. Samples were blocked by incubation for 1 h in 20% goat serum (with 0.3% Triton X-100 in PBS for whole mounts) at room temperature. For Cx30 detection, tissues were fixed by immersion in 2% paraformaldehyde for 20 min. For albumin and Ig detection, blood was washed out by intracardiac perfusion for 10 min, first with PBS and then with 4% paraformaldehyde. The inner ear was then dissected. Samples were incubated with the primary antibody in 1% goat serum (with 0.1% TritonX-100 in PBS for whole mounts) at 4°C for 12 h, rinsed three times in PBS, incubated with the secondary antibody diluted in PBS for 1 h at room temperature, and embedded in Fluorsave (Calbiochem) for confocal microscopy analysis (Zeiss, Jena, Germany; LSM510 META). We assessed the specificity of antibodies against Hcy by immunolabeling of liver sections from wild-type and cystathionine ␤-synthase-deficient mice (data not shown) (38) . Tissues from at least three animals were used in each experiment.
Transmission Electron Microscopy. Anesthetized mice were perfused, by the left ventricle, with 2.0% paraformaldehyde and 0.2% glutaraldehyde in PBS. Strips of SV attached to the underlying spiral ligament were dissected, kept in fixative for 2 h, and then immersed in 1.0% OsO4 for 1 h at 4°C. Tissues were rinsed, dehydrated in a graded series of ethanol concentrations, stained with 2% uranyl acetate for 1 h, and embedded in Spurr's resin. Serial sections (70 nm) were cut and examined in a 1200EX Jeol (Tokyo, Japan) electron microscope.
Freeze-Fracture Experiments. Anesthetized mice were perfused, by the left ventricle, with 0.1% xylocaine, followed by 0.1% glutaraldehyde. SVs were dissected out and fixed by immersion in 2.5% glutaraldehyde in PBS for 1 h, infiltrated with 30% glycerol, frozen in Freon22 cooled in liquid nitrogen, and processed for freezefracture, by using a BAF060 Freeze Etching System (BAL-TEC, Liechtenstein). For each genotype, replicas from at least 10 SVs were screened under a Philips (Eindhoven, The Netherlands) CM10 electron microscope. The area of individual GJ plaques was measured by planimetry, by using a graphic tablet connected to a Quantimet Leica 500ϩ apparatus (Leica, Cambridge, U.K.).
HRP Tracer Experiment. Mice were anesthetized, and temporal bones were dissected in PBS containing 1 mM CaCl 2 . The scala tympani and scala vestibuli of cochleas were perfused with 1% HRP (grade VI; Sigma) in PBS containing 1 mM CaCl 2 for 5 min at 4°C, through the round and oval windows, respectively. The Reissner's membrane was broken during the HRP injection, allowing penetration of the tracer protein also into the scala media. Excess of HRP was removed by flushing PBS containing 1 mM CaCl 2 , and cochleas were fixed with 2.5% paraformaldehyde/2% glutaraldehyde in PBS for 2 h. After an overnight wash with PBS, cochleas were incubated in diaminobenzidine (Vector Laboratories, Burlingame, CA), post-fixed in 1% osmium tetroxide for 1 h, dehydrated in ethanol, and embedded in Spurr's resin.
Dye-Coupling Experiments. Freshly dissected SV were attached to Sylgard-and poly-L-lysine-coated dishes, and individual cells were impaled under visual control, using a glass microelectrode filled with either 4% NBN or 4% LY CH (Sigma). Tracers were injected iontophoretically for 5 min by using 0.1-nA negative (LY) or positive (NBN) square pulses of 900-ms duration and a frequency of 0.5 Hz. SVs were fixed in 4% paraformaldehyde in PBS and used for immunohistochemistry and confocal microscopy analysis.
Microarray Analysis. Total RNA from dissected SVs of Cx30 Ϫ/Ϫ and wild-type mice at P13 [an age at which no cellular defect could be detected in the organ of Corti of Cx30 Ϫ/Ϫ mice (6)] was extracted by using TRIzol reagent (Invitrogen), purified on Rneasy columns (Qiagen, Valencia, CA), and tested on an Agilent (Waldbronn, Germany) 2100 Bioanalyzer. cRNAs obtained from 100 ng of RNA were amplified by using the GeneChip Expression Two-Cycle 3Ј amplification system (Affymetrix, High Wycombe, U.K.). Fragmented biotin-labeled cRNA samples were hybridized on 430A 2.0 GeneChip Mouse Genome arrays. Three arrays were used for each genotype. Cell intensity files were generated with GeneChipOperating Software. Data were analyzed with SPlus ArrayAnalyser software (Insightfull Corp., Seattle, WA) and processed by the Robust Multichip Analysis method. Arrays were compared using the Local Pool Error test. The P values were adjusted by using the Benjamini-Hochberg algorithm.
Quantification of Bhmt mRNA. Bhmt transcription was quantified by SYBR green RT-PCR (Applied Biosystems, Buckinghamshire, U.K.). Bhmt mRNA levels were normalized with respect to hypoxanthine-guanine phosphoribosyltransferase (Hprt) mRNA levels, a housekeeping gene transcript that is present at the same level in all tissues. Primers: Bhmt.f 5Ј-CTGGGGAAGTGGTT-TGGACA-3Ј and Bhmt.r 5Ј-GCCGGAAGCTATTCGCA-GAT-3Ј (working concentration, 900 nM); Hprt.f 5Ј-GTTG-GATACAGGCCAGACTTTGTTG-3Ј and Hprt.r 5Ј-GAT-TCAACTTGCGCTCATCTTAGGC-3Ј (working concentration, 300 nM). PCR experiments were performed in triplicate on an ABI Prism 7700 (Applied Biosystems). The relative abundance of amplified cDNA was calculated as 2 Ϫ⌬Ct , where change in cycle threshold (⌬Ct) equals Ct of Bhmt in wild-type mice Ϫ Ct of Bhmt in Cx30 Ϫ/Ϫ mice. Results are expressed as means of 2 Ϫ⌬Ct Bhmt/2
Ϫ⌬Ct Hprt values. Two independent experiments were performed for each tissue.
HPLC Measurements of Blood Concentrations of Cysteine Derivatives.
Blood samples were collected into EDTA-containing tubes and cooled at 4°C. Plasma was separated by centrifugation at 2,000 ϫ g for 15 min at 4°C. Total Hcy, cysteine, glutathione, and cysteinylglycine contents were determined in plasma, using a fluorometric HPLC method with a C-18 reverse-phase column [250 ϫ 4-mm LiChrospher 100 RP-18, with 5-m endcapped beads (Merck, Darmstadt, Germany)] at room temperature. D,L-Hcy, L-cysteine, reduced glutathione, cysteinylglycine, N-acetyl-L-cysteine (Sigma), and 7-fluoro-2-oxa-1,3-diazole-4-sulfonate and tri-n-butylphosphine (Fluka, Buchs, Switzerland) were used as references. Nacetyl-L-cysteine was added to 60 l of plasma as an internal standard, the samples were reduced with tri-n-butylphosphine, proteins were precipitated with HClO 4 , and the supernatant was made alkaline with K 2 B 4 O 7 , derivatized with 7-fluoro-2,1,3-benzoxaazole-4-sulfonamide (SBDF), and separated by HPLC with fluorescence detection. Calibration curves were obtained by adding eight concentrations (0-100 M) of Hcy, L-cysteine, glutathione, or cysteinylglycine to a plasma pool, which was used in each run. Interand intraassay coefficients of variation for mean total Hcy concentration were 4.2% and 6.3%, respectively, and the curve was linear from 2.5 to 100 M.
